Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Retraction: MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4.

[No authors listed]

PLoS One. 2013 May 20;8(5). doi: 10.1371/annotation/aaef10de-ee36-416f-93eb-959dfa3dc92e. Print 2013. No abstract available.

2.

miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer.

Hwang MS, Yu N, Stinson SY, Yue P, Newman RJ, Allan BB, Dornan D.

PLoS One. 2013 Jun 11;8(6):e66502. doi: 10.1371/journal.pone.0066502. Print 2013.

3.

miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling.

Xia H, Cheung WK, Sze J, Lu G, Jiang S, Yao H, Bian XW, Poon WS, Kung HF, Lin MC.

J Biol Chem. 2010 Nov 19;285(47):36995-7004. doi: 10.1074/jbc.M110.133744. Epub 2010 Sep 7.

4.

Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation.

Wang G, Guo X, Hong W, Liu Q, Wei T, Lu C, Gao L, Ye D, Zhou Y, Chen J, Wang J, Wu M, Liu H, Kang J.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2858-63. doi: 10.1073/pnas.1212769110. Epub 2013 Feb 5.

5.

miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines.

Arora H, Qureshi R, Park WY.

PLoS One. 2013 May 22;8(5):e64273. doi: 10.1371/journal.pone.0064273. Print 2013.

6.

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.

Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C.

PLoS One. 2012;7(6):e39520. doi: 10.1371/journal.pone.0039520. Epub 2012 Jun 25.

7.

MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.

Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, Wu Z, Chen T, Wu W, Lobie PE, Zhu T.

PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2.

8.

MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.

Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N, Zhu Z, Mo Z, Wu C, Chen X.

Cancer Sci. 2012 Jun;103(6):1058-64. doi: 10.1111/j.1349-7006.2012.02281.x. Epub 2012 Apr 23.

9.

Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.

Lim YY, Wright JA, Attema JL, Gregory PA, Bert AG, Smith E, Thomas D, Lopez AF, Drew PA, Khew-Goodall Y, Goodall GJ.

J Cell Sci. 2013 May 15;126(Pt 10):2256-66. doi: 10.1242/jcs.122275. Epub 2013 Mar 22.

10.

MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells.

Turcatel G, Rubin N, El-Hashash A, Warburton D.

PLoS One. 2012;7(1):e31032. doi: 10.1371/journal.pone.0031032. Epub 2012 Jan 27.

11.

The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.

Zhang Z, Liu ZB, Ren WM, Ye XG, Zhang YY.

Int J Mol Med. 2012 Oct;30(4):856-62. doi: 10.3892/ijmm.2012.1059. Epub 2012 Jul 12.

PMID:
22797360
12.

OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.

Dai X, Ge J, Wang X, Qian X, Zhang C, Li X.

Oncol Rep. 2013 Jan;29(1):155-60. doi: 10.3892/or.2012.2086. Epub 2012 Oct 17.

PMID:
23076549
13.

Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.

Ren D, Wang M, Guo W, Zhao X, Tu X, Huang S, Zou X, Peng X.

Int J Oncol. 2013 Apr;42(4):1473-81. doi: 10.3892/ijo.2013.1825. Epub 2013 Feb 12.

PMID:
23404342
14.

Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.

Lu MH, Huang CC, Pan MR, Chen HH, Hung WC.

Clin Cancer Res. 2012 Dec 1;18(23):6416-25. doi: 10.1158/1078-0432.CCR-12-0832. Epub 2012 Oct 8.

15.

miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin.

Hamada S, Satoh K, Miura S, Hirota M, Kanno A, Masamune A, Kikuta K, Kume K, Unno J, Egawa S, Motoi F, Unno M, Shimosegawa T.

J Cell Physiol. 2013 Jun;228(6):1255-63. doi: 10.1002/jcp.24280.

PMID:
23139153
16.

MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.

Jurmeister S, Baumann M, Balwierz A, Keklikoglou I, Ward A, Uhlmann S, Zhang JD, Wiemann S, Sahin Ö.

Mol Cell Biol. 2012 Feb;32(3):633-51. doi: 10.1128/MCB.06212-11. Epub 2011 Dec 5.

17.

The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression.

Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, Wen P, Yang J.

Am J Physiol Renal Physiol. 2012 Feb 1;302(3):F369-79. doi: 10.1152/ajprenal.00268.2011. Epub 2011 Oct 19.

18.

miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.

Uhlmann S, Zhang JD, Schwäger A, Mannsperger H, Riazalhosseini Y, Burmester S, Ward A, Korf U, Wiemann S, Sahin O.

Oncogene. 2010 Jul 29;29(30):4297-306. doi: 10.1038/onc.2010.201. Epub 2010 May 31.

PMID:
20514023
19.

ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer.

Guttilla IK, Adams BD, White BA.

Trends Endocrinol Metab. 2012 Feb;23(2):73-82. doi: 10.1016/j.tem.2011.12.001. Epub 2012 Jan 16. Review.

PMID:
22257677
20.

MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.

Yu F, Jiao Y, Zhu Y, Wang Y, Zhu J, Cui X, Liu Y, He Y, Park EY, Zhang H, Lv X, Ma K, Su F, Park JH, Song E.

J Biol Chem. 2012 Jan 2;287(1):465-73. doi: 10.1074/jbc.M111.280768. Epub 2011 Nov 10.

Supplemental Content

Support Center